Main menu button

News

Carlsquare weekly market letter: Commodity bull run– when will it affect inflation?
22 Mai 2024
Carlsquare weekly market letter: Commodity bull run– when will it affect inflation?
Equity Research Carlsquare
Equity Research GIAB, Q1 2024: Third savings programme to break even
21 Mai 2024
Equity Research GIAB, Q1 2024: Third savings programme to break even
Equity Research
Equity Research Ecoclime, Q1 2024: Sales growth possible after weak quarter
20 Mai 2024
Equity Research Ecoclime, Q1 2024: Sales growth possible after weak quarter
Equity Research
Equity research Viva Wine Group, Q1 2024: Solid cost control improves longterm outlook
20 Mai 2024
Equity research Viva Wine Group, Q1 2024: Solid cost control improves longterm outlook
Equity Research Viva Wine Group
Equity research Nosa Plugs Q1, 2024: Tepid Q1 and updated company strategy
17 Mai 2024
Equity research Nosa Plugs Q1, 2024: Tepid Q1 and updated company strategy
Equity Research Nosa Plugs
Carlsquare hat bei der Fremdfinanzierung des Erwerbs des deutschen Vertriebsunternehmens Unigloves durch UG Healthcare Corporation beraten
16 Mai 2024
Carlsquare hat bei der Fremdfinanzierung des Erwerbs des deutschen Vertriebsunternehmens Unigloves durch UG Healthcare Corporation beraten
Deal News
Equity Research Ecoclime Q1 2024: A weak quarter but continued growth for Evertherm
16 Mai 2024
Equity Research Ecoclime Q1 2024: A weak quarter but continued growth for Evertherm
Equity Research
Equity Research GIAB Q1 2024: Slightly higher sales, but new savings needed
16 Mai 2024
Equity Research GIAB Q1 2024: Slightly higher sales, but new savings needed
Equity Research
Equity research Viva Wine Group, Q1 2024: Profitability above our expectations despite soft top-line
16 Mai 2024
Equity research Viva Wine Group, Q1 2024: Profitability above our expectations despite soft top-line
Equity Research Viva Wine Group
Equity research HANZA Q1, 2024: Temporarily in a lower orbit
15 Mai 2024
Equity research HANZA Q1, 2024: Temporarily in a lower orbit
Equity Research Hanza
Carlsquare weekly market letter: Interest rates at a crossroads - will affect the whole market
15 Mai 2024
Carlsquare weekly market letter: Interest rates at a crossroads - will affect the whole market
Equity Research Carlsquare
Podcast Close the Deal mit Carlsquare-Founder Mark Miller
14 Mai 2024
Podcast Close the Deal mit Carlsquare-Founder Mark Miller
In den Medien
Equity Research InCoax, Q1 2024: Strong start to 2024
10 Mai 2024
Equity Research InCoax, Q1 2024: Strong start to 2024
Equity Research InCoax
This was the OMR24 After-Event in Hamburg
08 Mai 2024
This was the OMR24 After-Event in Hamburg
Events
Equity Research Svenska Aerogel, Q1 2024: Streamlining to reduce costs
08 Mai 2024
Equity Research Svenska Aerogel, Q1 2024: Streamlining to reduce costs
Equity Research Svenska Aerogel
Carlsquare weekly market letter: Sell in May and stay away?
08 Mai 2024
Carlsquare weekly market letter: Sell in May and stay away?
Equity Research Carlsquare
First Impression InCoax Q1 2024: Much better sales and results than expected
07 Mai 2024
First Impression InCoax Q1 2024: Much better sales and results than expected
Equity Research InCoax
Equity research HANZA: First impression Q1 2024
07 Mai 2024
Equity research HANZA: First impression Q1 2024
Equity Research Hanza
Carlsquare hat den Business-Messaging-Experten LEKAB bei der Zusammenschluss mit dem norwegischen Konkurrenten Eurobate beraten
07 Mai 2024
Carlsquare hat den Business-Messaging-Experten LEKAB bei der Zusammenschluss mit dem norwegischen Konkurrenten Eurobate beraten
Deal News
2024 wird ein starkes Jahr für IPOs, und die hochinnovative Medtech Branche ist gut positioniert, um davon zu profitieren
06 Mai 2024
2024 wird ein starkes Jahr für IPOs, und die hochinnovative Medtech Branche ist gut positioniert, um davon zu profitieren
Insights